Cytomegalovirus infection epidemiology and demographics: Difference between revisions
| Line 11: | Line 11: | ||
*CMV seroprevalence in developing countries reaches more than 90% by [[adolescence]] and exceeds 95% by early adulthood. | *CMV seroprevalence in developing countries reaches more than 90% by [[adolescence]] and exceeds 95% by early adulthood. | ||
* In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection. | * In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection. | ||
===Age=== | |||
*Seroprevalence is age-dependent 58.9% of individuals aged 6 and over are infected with CMV and 90.8% of individuals aged 80 and over are positive for CMV.[1] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:24, 30 May 2017
|
Cytomegalovirus infection Microchapters |
|
Differentiating Cytomegalovirus infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cytomegalovirus infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cytomegalovirus infection epidemiology and demographics |
|
FDA on Cytomegalovirus infection epidemiology and demographics |
|
CDC on Cytomegalovirus infection epidemiology and demographics |
|
Cytomegalovirus infection epidemiology and demographics in the news |
|
Blogs on Cytomegalovirus infection epidemiology and demographics |
|
Risk calculators and risk factors for Cytomegalovirus infection epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Overview
Cytomegalovirus (CMV) infection is seen approximately 40-90% of the world population.
Epidemiology and Demographics
Prevalence
- Cytomegalovirus (CMV) infects approximately 40-90% of the world population.[1]
- CMV seroprevalence in developing countries reaches more than 90% by adolescence and exceeds 95% by early adulthood.
- In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection.
===Age===
- Seroprevalence is age-dependent 58.9% of individuals aged 6 and over are infected with CMV and 90.8% of individuals aged 80 and over are positive for CMV.[1]
References
- ↑ Pytka D, Czarkowska-Pączek B (2016). "[CMV infection in elderly]". Przegl Lek. 73 (4): 241–4. PMID 27526428.